Capsaicin Protects Against Oxidative Insults and Alleviates Behavioral Deficits in Rats with 6-OHDA-Induced Parkinson's Disease via Activation of TRPV1
- PMID: 28861768
- DOI: 10.1007/s11064-017-2388-4
Capsaicin Protects Against Oxidative Insults and Alleviates Behavioral Deficits in Rats with 6-OHDA-Induced Parkinson's Disease via Activation of TRPV1
Abstract
Increasing evidence suggests that capsaicin may play a role in modulating neuronal function and controlling motor behavior. However, the underlying mechanism is still unclear and the activation of transient receptor potential vanilloid 1 (TRPV1) might be involved in. This study investigated the potential neuroprotective role of capsaicin in a rat model of 6-hydroxydopamine (6-OHDA)-induced Parkinson's disease (PD). Capsaicin was treated intraperitoneally for the 6-OHDA induced PD rats and the locomotor activity and abnormal involuntary movements were found alleviated. Besides, brain oxidative stress (lipid peroxidation, superoxide dismutase and catalase) was also assessed, and oxidative insults were investigated relieved. Both the expression of tyrosine hydroxylase and TRPV1 were increased in the striatal and substantia nigra areas of 6-OHDA induced rats after the treatment of capsaicin by the semi-quantitative analysis of Western Blot. And the immunostaining of substantia nigra further suggested that capsaicin might protect against dopaminergic neuronal loss. Our results showed that TRPV1 might be a novel therapeutic target for PD.
Keywords: Capsaicin; Neuroprotection; Parkinson’s disease; TRPV1.
Similar articles
-
Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.Neurobiol Dis. 2006 May;22(2):421-34. doi: 10.1016/j.nbd.2005.12.008. Epub 2006 Feb 9. Neurobiol Dis. 2006. PMID: 16480889
-
The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.J Pharm Pharmacol. 2004 May;56(5):649-54. doi: 10.1211/0022357023222. J Pharm Pharmacol. 2004. PMID: 15142343
-
Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.Neuroscience. 2016 Mar 24;318:157-65. doi: 10.1016/j.neuroscience.2016.01.020. Epub 2016 Jan 14. Neuroscience. 2016. PMID: 26777890 Free PMC article.
-
Beneficial Effects of Flavonoids Against Parkinson's Disease.J Med Food. 2018 May;21(5):421-432. doi: 10.1089/jmf.2017.4078. Epub 2018 Feb 7. J Med Food. 2018. PMID: 29412767 Review.
-
The Potential of L-Type Calcium Channels as a Drug Target for Neuroprotective Therapy in Parkinson's Disease.Annu Rev Pharmacol Toxicol. 2019 Jan 6;59:263-289. doi: 10.1146/annurev-pharmtox-010818-021214. Annu Rev Pharmacol Toxicol. 2019. PMID: 30625283 Review.
Cited by
-
Functional Crosstalk between CB and TRPV1 Receptors Protects Nigrostriatal Dopaminergic Neurons in the MPTP Model of Parkinson's Disease.J Immunol Res. 2020 Sep 28;2020:5093493. doi: 10.1155/2020/5093493. eCollection 2020. J Immunol Res. 2020. PMID: 33062722 Free PMC article.
-
Transient Receptor Potential Channels as an Emerging Target for the Treatment of Parkinson's Disease: An Insight Into Role of Pharmacological Interventions.Front Cell Dev Biol. 2020 Nov 20;8:584513. doi: 10.3389/fcell.2020.584513. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33330461 Free PMC article. Review.
-
Beneficial Effects of Capsaicin in Disorders of the Central Nervous System.Molecules. 2022 Apr 12;27(8):2484. doi: 10.3390/molecules27082484. Molecules. 2022. PMID: 35458680 Free PMC article. Review.
-
Neuroprotective and Symptomatic Effects of Cannabidiol in an Animal Model of Parkinson's Disease.Int J Mol Sci. 2021 Aug 18;22(16):8920. doi: 10.3390/ijms22168920. Int J Mol Sci. 2021. PMID: 34445626 Free PMC article.
-
Therapeutic Potential of Capsaicin in Various Neurodegenerative Diseases with Special Focus on Nrf2 Signaling.Curr Pharm Biotechnol. 2024;25(13):1693-1707. doi: 10.2174/0113892010277933231122111244. Curr Pharm Biotechnol. 2024. PMID: 38173062 Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical